E G Levin

4.2k total citations · 1 hit paper
41 papers, 3.0k citations indexed

About

E G Levin is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, E G Levin has authored 41 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 13 papers in Hematology and 12 papers in Molecular Biology. Recurrent topics in E G Levin's work include Protease and Inhibitor Mechanisms (13 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). E G Levin is often cited by papers focused on Protease and Inhibitor Mechanisms (13 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). E G Levin collaborates with scholars based in United States, Israel and Belgium. E G Levin's co-authors include Lydia Santell, David J. Loskutoff, Ulla M. Marzec, Yaniv Lustig, LA Harker, Victoria Indenbaum, Carmit Cohen, Gili Regev‐Yochay, Ilana Tal and Carmit Rubin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

E G Levin

41 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

2021 814 citations Yaniv Lustig, Carmit Cohen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E G Levin United States	22	986	851	848	538	429	41	3.0k
Fridtjof Lund‐Johansen Norway	35	656 0.7×	102 0.1×	869 1.0×	1.1k 2.0×	148 0.3×	94	4.9k
Gerhard Gaedicke Germany	28	364 0.4×	86 0.1×	748 0.9×	721 1.3×	270 0.6×	148	3.0k
Robert A. Sandhaus United States	31	149 0.2×	1.6k 1.8×	648 0.8×	774 1.4×	1.4k 3.4×	118	4.0k
Christopher J. Gibson United States	26	1.2k 1.2×	376 0.4×	1.4k 1.7×	682 1.3×	400 0.9×	72	4.2k
Geir E. Tjønnfjord Norway	37	509 0.5×	83 0.1×	2.9k 3.4×	722 1.3×	233 0.5×	217	5.7k
Danièl Thomas United States	31	90 0.1×	546 0.6×	1.4k 1.7×	1.8k 3.3×	217 0.5×	117	4.0k
Kevin M. Elias United States	30	245 0.2×	440 0.5×	93 0.1×	805 1.5×	252 0.6×	152	4.6k
Jacek Roliński Poland	33	162 0.2×	278 0.3×	326 0.4×	786 1.5×	268 0.6×	270	4.9k
Adriana Rojas‐Villarraga Colombia	37	452 0.5×	90 0.1×	269 0.3×	435 0.8×	286 0.7×	150	4.2k
Christian M. Hedrich Germany	47	635 0.6×	251 0.3×	540 0.6×	1.4k 2.6×	269 0.6×	162	5.7k

Countries citing papers authored by E G Levin

Since Specialization

Citations

This map shows the geographic impact of E G Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E G Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E G Levin more than expected).

Fields of papers citing papers by E G Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E G Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E G Levin. The network helps show where E G Levin may publish in the future.

Co-authorship network of co-authors of E G Levin

This figure shows the co-authorship network connecting the top 25 collaborators of E G Levin. A scholar is included among the top collaborators of E G Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E G Levin. E G Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levin, E G, Amit Ritter, Thomas Shpitzer, et al.. (2024). Management and prognosis of iatrogenic perforations of the cervical oesophagus and hypopharynx. Acta Otorhinolaryngologica Italica. 44(4). 214–222. 1 indexed citations

Levin, E G, Amit Ritter, Gideon Bachar, et al.. (2024). Management of laryngeal chondroradionecrosis: A single‐center experience. Head & Neck. 47(1). 300–308. 1 indexed citations

Magen, Hila, Abraham Avigdor, Shalev Fried, et al.. (2023). Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders. PLoS ONE. 18(5). e0284925–e0284925. 1 indexed citations

Levin, E G, et al.. (2023). Long-term complications associated with the management of sinonasal malignancies: a single center experience. Acta Otorhinolaryngologica Italica. 43(3). 203–211. 2 indexed citations

Margalit, Ofer, Einat Shacham‐Shmueli, Raanan Berger, et al.. (2022). Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours. European Journal of Cancer. 168. 51–55. 5 indexed citations

Bachar, Gideon, et al.. (2022). Proliferative verrucous leukoplakia: a clinicopathological comparative study. International Journal of Oral and Maxillofacial Surgery. 51(8). 1027–1033. 8 indexed citations

Schwartz, A., Shlomi Toussia‐Cohen, Tzipora Strauss, et al.. (2021). Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine. American Journal of Obstetrics and Gynecology. 225(5). 577–579. 15 indexed citations

Shmueli, Einat, Ofer Margalit, Raanan Berger, et al.. (2021). Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study. European Journal of Cancer. 157. 124–131. 31 indexed citations

Levy, Itzchak, Anat Wieder-Finesod, Asaf Biber, et al.. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clinical Microbiology and Infection. 27(12). 1851–1855. 112 indexed citations

10.

Gilboa, Mayan, Ilana Tal, E G Levin, et al.. (2021). Coronavirus disease 2019 (COVID-19) vaccination uptake among healthcare workers. Infection Control and Hospital Epidemiology. 43(10). 1433–1438. 12 indexed citations

11.

Linder, Nehama, Tali Vishne, E G Levin, et al.. (2002). Hepatitis B Vaccination: Long-Term Follow-up of the Immune Response of Preterm Infants and Comparison of Two Vaccination Protocols. Infection. 30(3). 136–139. 32 indexed citations

12.

Linder, Nehama, Ron Dagan, G. Ohel, et al.. (1999). Decline of hepatitis a antibodies during the first 7 months of life in full-term and preterm infants. Infection. 27(2). 128–131. 15 indexed citations

13.

Levin, E G, Lindsey A. Miles, G M Fless, et al.. (1994). Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 14(3). 438–442. 73 indexed citations

14.

Levin, E G & Gregory J. del Zoppo. (1994). Localization of tissue plasminogen activator in the endothelium of a limited number of vessels.. PubMed. 144(5). 855–61. 98 indexed citations

15.

Levin, E G, et al.. (1993). Hyperosmotic stress stimulates tissue plasminogen activator expression by a PKC-independent pathway. American Journal of Physiology-Cell Physiology. 265(2). C387–C396. 26 indexed citations

16.

Levin, E G, et al.. (1991). Thrombin and the thrombin-thrombomodulin complex interaction with plasminogen activator inhibitor type-1. Blood Coagulation & Fibrinolysis. 2(3). 471–476. 4 indexed citations

17.

Levin, E G & Lydia Santell. (1991). Phosphorylation of an Mr = 29,000 protein by IL-1 is susceptible to partial down-regulation after endothelial cell activation. The Journal of Immunology. 146(11). 3772–3778. 10 indexed citations

18.

Idell, Steven, E G Levin, Bradford S. Schwartz, et al.. (1989). Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome.. Journal of Clinical Investigation. 84(2). 695–705. 265 indexed citations

19.

Levin, E G, K.R. Marotti, & Lydia Santell. (1989). Protein Kinase C and the Stimulation of Tissue Plasminogen Activator Release from Human Endothelial Cells. Journal of Biological Chemistry. 264(27). 16030–16036. 63 indexed citations

20.

Harker, Laurence A., et al.. (1987). DEMONSTRATION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR (scu-PA) ON HUMAN PLATELET MEMBRANES. Thrombosis and Haemostasis. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact